Abpro Bio Decides to Issue 3 Billion KRW Convertible Bonds with Conversion Price Adjusted to 1,390 Won, 7.95% Dilution Risk
Abpro Bio has decided to issue 3 billion KRW worth of unregistered private placement convertible bonds. The conversion price was adjusted upward from 1,324 won to 1,390 won, slightly above the current stock price of 1,380 won.
The issuance will result in 2,265,861 new shares, equivalent to 7.95% of the total outstanding shares, potentially diluting existing shareholder value.
The raised 3 billion KRW is intended for acquisition of securities of other companies, but the specific target has not been determined, increasing uncertainty and investment risk.
The bondholder is Ra-eun Company, a newly established entity in 2025 with no disclosed financial information, indicating low transparency. The conversion is restricted for one year.
[AI Summary]Abpro Bio's 3 billion KRW convertible bond issuance carries a potential dilution of 7.95%, negative for shareholders, with unclear use of proceeds and low counterparty credibility. While the conversion price is above the current share price, future adjustments may occur if the stock declines.
KOSDAQ Filing Information
[Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)